nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Vincristine—muscle cancer	0.133	0.206	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.133	0.206	CbGbCtD
Triazolam—CYP3A5—Vincristine—muscle cancer	0.0995	0.155	CbGbCtD
Triazolam—CYP3A5—Etoposide—muscle cancer	0.0912	0.142	CbGbCtD
Triazolam—CYP2C8—Etoposide—muscle cancer	0.0877	0.136	CbGbCtD
Triazolam—CYP3A4—Vincristine—muscle cancer	0.0388	0.0604	CbGbCtD
Triazolam—CYP3A4—Etoposide—muscle cancer	0.0356	0.0553	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—muscle cancer	0.0243	0.0377	CbGbCtD
Triazolam—TSPO—hindlimb—muscle cancer	0.0166	0.0842	CbGeAlD
Triazolam—TSPO—appendage—muscle cancer	0.0142	0.0723	CbGeAlD
Triazolam—GABRR2—tendon—muscle cancer	0.00559	0.0284	CbGeAlD
Triazolam—GABRR3—head—muscle cancer	0.00553	0.0281	CbGeAlD
Triazolam—GABRQ—head—muscle cancer	0.00553	0.0281	CbGeAlD
Triazolam—GABRG3—head—muscle cancer	0.00484	0.0246	CbGeAlD
Triazolam—GABRR2—head—muscle cancer	0.00479	0.0244	CbGeAlD
Triazolam—TSPO—embryo—muscle cancer	0.00472	0.024	CbGeAlD
Triazolam—GABRG3—testis—muscle cancer	0.00468	0.0238	CbGeAlD
Triazolam—GABRR1—head—muscle cancer	0.00461	0.0235	CbGeAlD
Triazolam—GABRR1—testis—muscle cancer	0.00446	0.0227	CbGeAlD
Triazolam—GABRB1—vagina—muscle cancer	0.00405	0.0206	CbGeAlD
Triazolam—GABRD—head—muscle cancer	0.00401	0.0204	CbGeAlD
Triazolam—GABRA4—tendon—muscle cancer	0.00394	0.02	CbGeAlD
Triazolam—GABRD—testis—muscle cancer	0.00387	0.0197	CbGeAlD
Triazolam—GABRG1—head—muscle cancer	0.00386	0.0196	CbGeAlD
Triazolam—GABRA6—head—muscle cancer	0.00384	0.0195	CbGeAlD
Triazolam—GABRB1—head—muscle cancer	0.00374	0.019	CbGeAlD
Triazolam—GABRA5—head—muscle cancer	0.00372	0.0189	CbGeAlD
Triazolam—TSPO—smooth muscle tissue—muscle cancer	0.00371	0.0189	CbGeAlD
Triazolam—GABRP—vagina—muscle cancer	0.00363	0.0185	CbGeAlD
Triazolam—GABRA5—testis—muscle cancer	0.0036	0.0183	CbGeAlD
Triazolam—TSPO—renal system—muscle cancer	0.00357	0.0182	CbGeAlD
Triazolam—GABRA3—head—muscle cancer	0.00347	0.0176	CbGeAlD
Triazolam—GABRE—cardiac atrium—muscle cancer	0.00343	0.0174	CbGeAlD
Triazolam—GABRA4—head—muscle cancer	0.00338	0.0172	CbGeAlD
Triazolam—GABRP—head—muscle cancer	0.00335	0.0171	CbGeAlD
Triazolam—GABRA3—testis—muscle cancer	0.00335	0.017	CbGeAlD
Triazolam—TSPO—cardiac atrium—muscle cancer	0.0032	0.0163	CbGeAlD
Triazolam—Dysaesthesia—Doxorubicin—muscle cancer	0.00308	0.0192	CcSEcCtD
Triazolam—GABRE—tendon—muscle cancer	0.00299	0.0152	CbGeAlD
Triazolam—Hepatic failure—Dactinomycin—muscle cancer	0.00287	0.0178	CcSEcCtD
Triazolam—GABRG2—head—muscle cancer	0.00283	0.0144	CbGeAlD
Triazolam—GABRB2—head—muscle cancer	0.00283	0.0144	CbGeAlD
Triazolam—GABRA2—vagina—muscle cancer	0.00279	0.0142	CbGeAlD
Triazolam—TSPO—tendon—muscle cancer	0.00279	0.0142	CbGeAlD
Triazolam—GABRE—vagina—muscle cancer	0.00277	0.0141	CbGeAlD
Triazolam—GABRB2—testis—muscle cancer	0.00273	0.0139	CbGeAlD
Triazolam—TSPO—bone marrow—muscle cancer	0.0027	0.0137	CbGeAlD
Triazolam—TSPO—vagina—muscle cancer	0.00259	0.0132	CbGeAlD
Triazolam—GABRA2—head—muscle cancer	0.00258	0.0131	CbGeAlD
Triazolam—Deafness—Vincristine—muscle cancer	0.00257	0.016	CcSEcCtD
Triazolam—Hepatic failure—Vincristine—muscle cancer	0.00256	0.0159	CcSEcCtD
Triazolam—GABRE—head—muscle cancer	0.00256	0.013	CbGeAlD
Triazolam—GABRA1—head—muscle cancer	0.00249	0.0127	CbGeAlD
Triazolam—GABRE—testis—muscle cancer	0.00247	0.0126	CbGeAlD
Triazolam—CYP2C8—renal system—muscle cancer	0.00245	0.0125	CbGeAlD
Triazolam—TSPO—head—muscle cancer	0.00239	0.0122	CbGeAlD
Triazolam—TSPO—testis—muscle cancer	0.00231	0.0117	CbGeAlD
Triazolam—CYP3A5—renal system—muscle cancer	0.00221	0.0112	CbGeAlD
Triazolam—Urinary retention—Vincristine—muscle cancer	0.00219	0.0136	CcSEcCtD
Triazolam—GABRB3—head—muscle cancer	0.00217	0.011	CbGeAlD
Triazolam—Ataxia—Vincristine—muscle cancer	0.00217	0.0135	CcSEcCtD
Triazolam—GABRB3—testis—muscle cancer	0.0021	0.0107	CbGeAlD
Triazolam—Muscular weakness—Vincristine—muscle cancer	0.00203	0.0126	CcSEcCtD
Triazolam—Redness—Doxorubicin—muscle cancer	0.00197	0.0123	CcSEcCtD
Triazolam—Stomatitis—Dactinomycin—muscle cancer	0.00194	0.012	CcSEcCtD
Triazolam—Dysuria—Vincristine—muscle cancer	0.00186	0.0116	CcSEcCtD
Triazolam—CYP2C8—vagina—muscle cancer	0.00178	0.00903	CbGeAlD
Triazolam—Stomatitis—Vincristine—muscle cancer	0.00173	0.0108	CcSEcCtD
Triazolam—Cramp muscle—Etoposide—muscle cancer	0.00168	0.0104	CcSEcCtD
Triazolam—Glossitis—Methotrexate—muscle cancer	0.00167	0.0104	CcSEcCtD
Triazolam—CYP3A4—renal system—muscle cancer	0.00166	0.00844	CbGeAlD
Triazolam—Dysarthria—Methotrexate—muscle cancer	0.00163	0.0101	CcSEcCtD
Triazolam—CYP3A5—vagina—muscle cancer	0.0016	0.00815	CbGeAlD
Triazolam—Hallucination—Vincristine—muscle cancer	0.00158	0.00986	CcSEcCtD
Triazolam—CYP2C8—testis—muscle cancer	0.00158	0.00806	CbGeAlD
Triazolam—Sweating increased—Etoposide—muscle cancer	0.00157	0.00977	CcSEcCtD
Triazolam—Erythema—Dactinomycin—muscle cancer	0.00155	0.00966	CcSEcCtD
Triazolam—Depressed level of consciousness—Methotrexate—muscle cancer	0.00149	0.00925	CcSEcCtD
Triazolam—Thinking abnormal—Doxorubicin—muscle cancer	0.00146	0.00906	CcSEcCtD
Triazolam—Glossitis—Doxorubicin—muscle cancer	0.00145	0.009	CcSEcCtD
Triazolam—Ill-defined disorder—Dactinomycin—muscle cancer	0.00144	0.00896	CcSEcCtD
Triazolam—Dysarthria—Doxorubicin—muscle cancer	0.00141	0.00877	CcSEcCtD
Triazolam—Stomatitis—Etoposide—muscle cancer	0.0014	0.00872	CcSEcCtD
Triazolam—Jaundice—Etoposide—muscle cancer	0.0014	0.00872	CcSEcCtD
Triazolam—Malaise—Dactinomycin—muscle cancer	0.0014	0.00871	CcSEcCtD
Triazolam—Coordination abnormal—Doxorubicin—muscle cancer	0.00136	0.00844	CcSEcCtD
Triazolam—Discomfort—Dactinomycin—muscle cancer	0.00131	0.00812	CcSEcCtD
Triazolam—Agitation—Vincristine—muscle cancer	0.00127	0.00793	CcSEcCtD
Triazolam—Oedema—Dactinomycin—muscle cancer	0.00127	0.00788	CcSEcCtD
Triazolam—Hepatic failure—Methotrexate—muscle cancer	0.00124	0.00773	CcSEcCtD
Triazolam—Anorexia—Dactinomycin—muscle cancer	0.00121	0.00751	CcSEcCtD
Triazolam—Hypertension—Vincristine—muscle cancer	0.0012	0.00745	CcSEcCtD
Triazolam—Visual disturbance—Methotrexate—muscle cancer	0.00118	0.00733	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—muscle cancer	0.00116	0.00719	CcSEcCtD
Triazolam—Oedema—Vincristine—muscle cancer	0.00113	0.00704	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—muscle cancer	0.00112	0.00695	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—muscle cancer	0.0011	0.00685	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—muscle cancer	0.0011	0.00684	CcSEcCtD
Triazolam—Hyperhidrosis—Vincristine—muscle cancer	0.00109	0.00681	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—muscle cancer	0.00109	0.00679	CcSEcCtD
Triazolam—Pain—Dactinomycin—muscle cancer	0.00108	0.00674	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—muscle cancer	0.00108	0.00672	CcSEcCtD
Triazolam—Anorexia—Vincristine—muscle cancer	0.00108	0.00671	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—muscle cancer	0.00108	0.0067	CcSEcCtD
Triazolam—Irritability—Methotrexate—muscle cancer	0.00107	0.00663	CcSEcCtD
Triazolam—Mood swings—Methotrexate—muscle cancer	0.00106	0.00658	CcSEcCtD
Triazolam—Ataxia—Methotrexate—muscle cancer	0.00105	0.00654	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—muscle cancer	0.00104	0.00649	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—muscle cancer	0.00104	0.00648	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00104	0.00644	CcSEcCtD
Triazolam—Insomnia—Vincristine—muscle cancer	0.00102	0.00637	CcSEcCtD
Triazolam—Paraesthesia—Vincristine—muscle cancer	0.00102	0.00632	CcSEcCtD
Triazolam—Malaise—Etoposide—muscle cancer	0.00101	0.0063	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—muscle cancer	0.001	0.00623	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—muscle cancer	0.000987	0.00614	CcSEcCtD
Triazolam—Decreased appetite—Vincristine—muscle cancer	0.000984	0.00612	CcSEcCtD
Triazolam—Fatigue—Vincristine—muscle cancer	0.000976	0.00607	CcSEcCtD
Triazolam—Hypertension—Etoposide—muscle cancer	0.00097	0.00603	CcSEcCtD
Triazolam—Constipation—Vincristine—muscle cancer	0.000968	0.00602	CcSEcCtD
Triazolam—Pain—Vincristine—muscle cancer	0.000968	0.00602	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—muscle cancer	0.000967	0.00602	CcSEcCtD
Triazolam—Chest pain—Etoposide—muscle cancer	0.000956	0.00595	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—muscle cancer	0.000952	0.00592	CcSEcCtD
Triazolam—Discomfort—Etoposide—muscle cancer	0.000945	0.00588	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—muscle cancer	0.000933	0.00581	CcSEcCtD
Triazolam—Gastrointestinal pain—Vincristine—muscle cancer	0.000925	0.00576	CcSEcCtD
Triazolam—Confusional state—Etoposide—muscle cancer	0.000924	0.00575	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—muscle cancer	0.000916	0.0057	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—muscle cancer	0.00091	0.00566	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—muscle cancer	0.000909	0.00565	CcSEcCtD
Triazolam—Dysuria—Methotrexate—muscle cancer	0.000903	0.00562	CcSEcCtD
Triazolam—Tachycardia—Etoposide—muscle cancer	0.000895	0.00557	CcSEcCtD
Triazolam—Abdominal pain—Vincristine—muscle cancer	0.000895	0.00557	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—muscle cancer	0.000886	0.00551	CcSEcCtD
Triazolam—Anorexia—Etoposide—muscle cancer	0.000874	0.00544	CcSEcCtD
Triazolam—Diarrhoea—Dactinomycin—muscle cancer	0.000867	0.00539	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—muscle cancer	0.000861	0.00536	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—muscle cancer	0.000853	0.00531	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—muscle cancer	0.000839	0.00522	CcSEcCtD
Triazolam—Hypersensitivity—Vincristine—muscle cancer	0.000834	0.00519	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—muscle cancer	0.000823	0.00512	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—muscle cancer	0.000817	0.00508	CcSEcCtD
Triazolam—Somnolence—Etoposide—muscle cancer	0.000815	0.00507	CcSEcCtD
Triazolam—Asthenia—Vincristine—muscle cancer	0.000812	0.00505	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—muscle cancer	0.000805	0.00501	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—muscle cancer	0.000797	0.00496	CcSEcCtD
Triazolam—Fatigue—Etoposide—muscle cancer	0.00079	0.00492	CcSEcCtD
Triazolam—Pain—Etoposide—muscle cancer	0.000784	0.00488	CcSEcCtD
Triazolam—Constipation—Etoposide—muscle cancer	0.000784	0.00488	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—muscle cancer	0.000782	0.00486	CcSEcCtD
Triazolam—Diarrhoea—Vincristine—muscle cancer	0.000774	0.00482	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—muscle cancer	0.000755	0.0047	CcSEcCtD
Triazolam—Nausea—Dactinomycin—muscle cancer	0.000752	0.00468	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—muscle cancer	0.00075	0.00466	CcSEcCtD
Triazolam—Dizziness—Vincristine—muscle cancer	0.000748	0.00466	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—muscle cancer	0.000746	0.00464	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—muscle cancer	0.000745	0.00463	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—muscle cancer	0.000727	0.00452	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—muscle cancer	0.000727	0.00452	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—muscle cancer	0.000725	0.00451	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—muscle cancer	0.000721	0.00448	CcSEcCtD
Triazolam—Vomiting—Vincristine—muscle cancer	0.00072	0.00448	CcSEcCtD
Triazolam—Dermatitis—Vincristine—muscle cancer	0.000713	0.00444	CcSEcCtD
Triazolam—Headache—Vincristine—muscle cancer	0.000709	0.00441	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—muscle cancer	0.000675	0.0042	CcSEcCtD
Triazolam—Erythema—Methotrexate—muscle cancer	0.000673	0.00419	CcSEcCtD
Triazolam—Nausea—Vincristine—muscle cancer	0.000672	0.00418	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—muscle cancer	0.000659	0.0041	CcSEcCtD
Triazolam—Asthenia—Etoposide—muscle cancer	0.000658	0.00409	CcSEcCtD
Triazolam—Pruritus—Etoposide—muscle cancer	0.000649	0.00404	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—muscle cancer	0.000645	0.00401	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—muscle cancer	0.000627	0.0039	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—muscle cancer	0.000624	0.00388	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—muscle cancer	0.000624	0.00388	CcSEcCtD
Triazolam—Malaise—Methotrexate—muscle cancer	0.000607	0.00377	CcSEcCtD
Triazolam—Dizziness—Etoposide—muscle cancer	0.000606	0.00377	CcSEcCtD
Triazolam—Vomiting—Etoposide—muscle cancer	0.000583	0.00363	CcSEcCtD
Triazolam—Erythema—Doxorubicin—muscle cancer	0.000583	0.00362	CcSEcCtD
Triazolam—Dermatitis—Etoposide—muscle cancer	0.000577	0.00359	CcSEcCtD
Triazolam—Headache—Etoposide—muscle cancer	0.000574	0.00357	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—muscle cancer	0.000574	0.00357	CcSEcCtD
Triazolam—Chest pain—Methotrexate—muscle cancer	0.000573	0.00356	CcSEcCtD
Triazolam—Tension—Doxorubicin—muscle cancer	0.000572	0.00356	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—muscle cancer	0.000571	0.00355	CcSEcCtD
Triazolam—Discomfort—Methotrexate—muscle cancer	0.000566	0.00352	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—muscle cancer	0.000566	0.00352	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—muscle cancer	0.00056	0.00348	CcSEcCtD
Triazolam—Confusional state—Methotrexate—muscle cancer	0.000554	0.00344	CcSEcCtD
Triazolam—Nausea—Etoposide—muscle cancer	0.000545	0.00339	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—muscle cancer	0.000541	0.00336	CcSEcCtD
Triazolam—Agitation—Doxorubicin—muscle cancer	0.000535	0.00333	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—muscle cancer	0.000531	0.0033	CcSEcCtD
Triazolam—Malaise—Doxorubicin—muscle cancer	0.000525	0.00327	CcSEcCtD
Triazolam—Anorexia—Methotrexate—muscle cancer	0.000523	0.00326	CcSEcCtD
Triazolam—Syncope—Doxorubicin—muscle cancer	0.000522	0.00325	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—muscle cancer	0.000515	0.0032	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—muscle cancer	0.000512	0.00319	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—muscle cancer	0.000503	0.00313	CcSEcCtD
Triazolam—Insomnia—Methotrexate—muscle cancer	0.000497	0.00309	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—muscle cancer	0.000496	0.00309	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—muscle cancer	0.000494	0.00308	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—muscle cancer	0.000493	0.00307	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—muscle cancer	0.00049	0.00305	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—muscle cancer	0.00049	0.00305	CcSEcCtD
Triazolam—Somnolence—Methotrexate—muscle cancer	0.000488	0.00304	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—muscle cancer	0.000485	0.00302	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—muscle cancer	0.000479	0.00298	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—muscle cancer	0.000477	0.00297	CcSEcCtD
Triazolam—Oedema—Doxorubicin—muscle cancer	0.000475	0.00296	CcSEcCtD
Triazolam—Fatigue—Methotrexate—muscle cancer	0.000473	0.00295	CcSEcCtD
Triazolam—Pain—Methotrexate—muscle cancer	0.00047	0.00292	CcSEcCtD
Triazolam—Shock—Doxorubicin—muscle cancer	0.000468	0.00291	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—muscle cancer	0.000464	0.00289	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—muscle cancer	0.00046	0.00286	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—muscle cancer	0.000453	0.00282	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—muscle cancer	0.000452	0.00282	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—muscle cancer	0.000449	0.00279	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—muscle cancer	0.000434	0.0027	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—muscle cancer	0.00043	0.00268	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—muscle cancer	0.000427	0.00266	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—muscle cancer	0.000424	0.00264	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—muscle cancer	0.000423	0.00263	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—muscle cancer	0.000413	0.00257	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—muscle cancer	0.00041	0.00255	CcSEcCtD
Triazolam—Pain—Doxorubicin—muscle cancer	0.000407	0.00253	CcSEcCtD
Triazolam—Constipation—Doxorubicin—muscle cancer	0.000407	0.00253	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—muscle cancer	0.000405	0.00252	CcSEcCtD
Triazolam—Asthenia—Methotrexate—muscle cancer	0.000394	0.00245	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—muscle cancer	0.000392	0.00244	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000389	0.00242	CcSEcCtD
Triazolam—Pruritus—Methotrexate—muscle cancer	0.000388	0.00242	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—muscle cancer	0.000376	0.00234	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—muscle cancer	0.000376	0.00234	CcSEcCtD
Triazolam—Dizziness—Methotrexate—muscle cancer	0.000363	0.00226	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—muscle cancer	0.00035	0.00218	CcSEcCtD
Triazolam—Vomiting—Methotrexate—muscle cancer	0.000349	0.00217	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—muscle cancer	0.000346	0.00215	CcSEcCtD
Triazolam—Headache—Methotrexate—muscle cancer	0.000344	0.00214	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—muscle cancer	0.000341	0.00212	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—muscle cancer	0.000336	0.00209	CcSEcCtD
Triazolam—Nausea—Methotrexate—muscle cancer	0.000326	0.00203	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—muscle cancer	0.000325	0.00202	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—muscle cancer	0.000314	0.00196	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—muscle cancer	0.000302	0.00188	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—muscle cancer	0.0003	0.00186	CcSEcCtD
Triazolam—Headache—Doxorubicin—muscle cancer	0.000298	0.00185	CcSEcCtD
Triazolam—Nausea—Doxorubicin—muscle cancer	0.000282	0.00176	CcSEcCtD
